2025. Durability of Response After Pausing Abrocitinib Treatment in Patients With Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s600. DOI:https://doi.org/10.25251/gaabwz65.